Vanguard Group Inc Kura Oncology, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,348,325 shares of KURA stock, worth $33.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,348,325
Previous 4,948,235
8.09%
Holding current value
$33.2 Million
Previous $32.7 Million
5.51%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding KURA
# of Institutions
188Shares Held
80.2MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$48.1 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$46.1 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$43.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$40.7 Million0.66% of portfolio
-
Ra Capital Management, L.P. Boston, MA4MShares$24.8 Million0.55% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $415M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...